Cargando…

The Roles of microRNAs in Cancer Multidrug Resistance

SIMPLE SUMMARY: The resistance of neoplastic cells to multiple drugs is a serious problem in cancer chemotherapy. The molecular causes of multidrug resistance in cancer are largely known, but less is known about the mechanisms by which cells deliver phenotypic changes that resist the attack of antic...

Descripción completa

Detalles Bibliográficos
Autores principales: Pavlíková, Lucia, Šereš, Mário, Breier, Albert, Sulová, Zdena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870231/
https://www.ncbi.nlm.nih.gov/pubmed/35205839
http://dx.doi.org/10.3390/cancers14041090
_version_ 1784656688982261760
author Pavlíková, Lucia
Šereš, Mário
Breier, Albert
Sulová, Zdena
author_facet Pavlíková, Lucia
Šereš, Mário
Breier, Albert
Sulová, Zdena
author_sort Pavlíková, Lucia
collection PubMed
description SIMPLE SUMMARY: The resistance of neoplastic cells to multiple drugs is a serious problem in cancer chemotherapy. The molecular causes of multidrug resistance in cancer are largely known, but less is known about the mechanisms by which cells deliver phenotypic changes that resist the attack of anticancer drugs. The findings of RNA interference based on microRNAs represented a breakthrough in biology and pointed to the possibility of sensitive and targeted regulation of gene expression at the post-transcriptional level. Such regulation is also involved in the development of multidrug resistance in cancer. The aim of the current paper is to summarize the available knowledge on the role of microRNAs in resistance to multiple cancer drugs. ABSTRACT: Cancer chemotherapy may induce a multidrug resistance (MDR) phenotype. The development of MDR is based on various molecular causes, of which the following are very common: induction of ABC transporter expression; induction/activation of drug-metabolizing enzymes; alteration of the expression/function of apoptosis-related proteins; changes in cell cycle checkpoints; elevated DNA repair mechanisms. Although these mechanisms of MDR are well described, information on their molecular interaction in overall multidrug resistance is still lacking. MicroRNA (miRNA) expression and subsequent RNA interference are candidates that could be important players in the interplay of MDR mechanisms. The regulation of post-transcriptional processes in the proteosynthetic pathway is considered to be a major function of miRNAs. Due to their complementarity, they are able to bind to target mRNAs, which prevents the mRNAs from interacting effectively with the ribosome, and subsequent degradation of the mRNAs can occur. The aim of this paper is to provide an overview of the possible role of miRNAs in the molecular mechanisms that lead to MDR. The possibility of considering miRNAs as either specific effectors or interesting targets for cancer therapy is also analyzed.
format Online
Article
Text
id pubmed-8870231
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-88702312022-02-25 The Roles of microRNAs in Cancer Multidrug Resistance Pavlíková, Lucia Šereš, Mário Breier, Albert Sulová, Zdena Cancers (Basel) Review SIMPLE SUMMARY: The resistance of neoplastic cells to multiple drugs is a serious problem in cancer chemotherapy. The molecular causes of multidrug resistance in cancer are largely known, but less is known about the mechanisms by which cells deliver phenotypic changes that resist the attack of anticancer drugs. The findings of RNA interference based on microRNAs represented a breakthrough in biology and pointed to the possibility of sensitive and targeted regulation of gene expression at the post-transcriptional level. Such regulation is also involved in the development of multidrug resistance in cancer. The aim of the current paper is to summarize the available knowledge on the role of microRNAs in resistance to multiple cancer drugs. ABSTRACT: Cancer chemotherapy may induce a multidrug resistance (MDR) phenotype. The development of MDR is based on various molecular causes, of which the following are very common: induction of ABC transporter expression; induction/activation of drug-metabolizing enzymes; alteration of the expression/function of apoptosis-related proteins; changes in cell cycle checkpoints; elevated DNA repair mechanisms. Although these mechanisms of MDR are well described, information on their molecular interaction in overall multidrug resistance is still lacking. MicroRNA (miRNA) expression and subsequent RNA interference are candidates that could be important players in the interplay of MDR mechanisms. The regulation of post-transcriptional processes in the proteosynthetic pathway is considered to be a major function of miRNAs. Due to their complementarity, they are able to bind to target mRNAs, which prevents the mRNAs from interacting effectively with the ribosome, and subsequent degradation of the mRNAs can occur. The aim of this paper is to provide an overview of the possible role of miRNAs in the molecular mechanisms that lead to MDR. The possibility of considering miRNAs as either specific effectors or interesting targets for cancer therapy is also analyzed. MDPI 2022-02-21 /pmc/articles/PMC8870231/ /pubmed/35205839 http://dx.doi.org/10.3390/cancers14041090 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Pavlíková, Lucia
Šereš, Mário
Breier, Albert
Sulová, Zdena
The Roles of microRNAs in Cancer Multidrug Resistance
title The Roles of microRNAs in Cancer Multidrug Resistance
title_full The Roles of microRNAs in Cancer Multidrug Resistance
title_fullStr The Roles of microRNAs in Cancer Multidrug Resistance
title_full_unstemmed The Roles of microRNAs in Cancer Multidrug Resistance
title_short The Roles of microRNAs in Cancer Multidrug Resistance
title_sort roles of micrornas in cancer multidrug resistance
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870231/
https://www.ncbi.nlm.nih.gov/pubmed/35205839
http://dx.doi.org/10.3390/cancers14041090
work_keys_str_mv AT pavlikovalucia therolesofmicrornasincancermultidrugresistance
AT seresmario therolesofmicrornasincancermultidrugresistance
AT breieralbert therolesofmicrornasincancermultidrugresistance
AT sulovazdena therolesofmicrornasincancermultidrugresistance
AT pavlikovalucia rolesofmicrornasincancermultidrugresistance
AT seresmario rolesofmicrornasincancermultidrugresistance
AT breieralbert rolesofmicrornasincancermultidrugresistance
AT sulovazdena rolesofmicrornasincancermultidrugresistance